UBS Maintains a 'Sell' on Westlake Chemical (WLK); Volumes and Vinyls Rebound
Tweet
Share
E-mailGet Alerts WLK Hot Sheet
Price: $79.55 -0.8%
Rating Summary:
8 Buy, 16 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
8 Buy, 16 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS maintains a 'Sell' on Westlake Chemical (NYSE: WLK) price target raised from $52 to $54.
Analyst, Andrew W. Cash, said, "WLK reported EPS of $1.31 in 1Q, ahead of the Consensus estimate of $1.22 and our estimate of $1.23. The company’s result included a $14 million or $0.21/s FIFO headwind. Volumes for olefins/polyolefins were especially strong and the Vinyls segment rebounded from a 4Q loss to post operating earnings of $21 million. Revenues were $1.03 billion were up 1.9% from 2011 and overall company sales volumes were up 13.8% for all products."
UBS raises FY12 EPS estimate from $5.00 to $5.15, but lowers FY13 from $5.90 to $5.80.
For an analyst ratings summary and ratings history on Westlake Chemical click here. For more ratings news on Westlake Chemical click here.
Shares of Westlake Chemical closed at $59.69 yesterday.
Analyst, Andrew W. Cash, said, "WLK reported EPS of $1.31 in 1Q, ahead of the Consensus estimate of $1.22 and our estimate of $1.23. The company’s result included a $14 million or $0.21/s FIFO headwind. Volumes for olefins/polyolefins were especially strong and the Vinyls segment rebounded from a 4Q loss to post operating earnings of $21 million. Revenues were $1.03 billion were up 1.9% from 2011 and overall company sales volumes were up 13.8% for all products."
UBS raises FY12 EPS estimate from $5.00 to $5.15, but lowers FY13 from $5.90 to $5.80.
For an analyst ratings summary and ratings history on Westlake Chemical click here. For more ratings news on Westlake Chemical click here.
Shares of Westlake Chemical closed at $59.69 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
- UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat
- Freedom Broker Upgrades Serve Robotics (SERV) to Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBS, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
